U01 CA182898/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	1
2012	6
2013	9
2014	9
2015	7
2016	14
2017	8
2018	3
2019	2
2020	2
2021	2
2022	2
2024	0

1

'Metabolically healthy obesity': origins and implications.

Denis GV, Obin MS. Denis GV, et al. Mol Aspects Med. 2013 Feb;34(1):59-70. doi: 10.1016/j.mam.2012.10.004. Epub 2012 Oct 13. Mol Aspects Med. 2013. PMID: 23068072 Free PMC article. Review.

2

The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities.

Ennis CS, Llevenes P, Qiu Y, Dries R, Denis GV. Ennis CS, et al. Front Endocrinol (Lausanne). 2022 Dec 1;13:1044670. doi: 10.3389/fendo.2022.1044670. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531496 Free PMC article. Review.

3

BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Andrieu GP, Shafran JS, Deeney JT, Bharadwaj KR, Rangarajan A, Denis GV. Andrieu GP, et al. J Leukoc Biol. 2018 Aug;104(2):265-274. doi: 10.1002/JLB.5RI0917-380RR. Epub 2018 Mar 1. J Leukoc Biol. 2018. PMID: 29493812 Free PMC article. Review.

4

BET domain co-regulators in obesity, inflammation and cancer.

Belkina AC, Denis GV. Belkina AC, et al. Nat Rev Cancer. 2012 Jun 22;12(7):465-77. doi: 10.1038/nrc3256. Nat Rev Cancer. 2012. PMID: 22722403 Free PMC article. Review.

5

Obesity genes and insulin resistance.

Belkina AC, Denis GV. Belkina AC, et al. Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):472-7. doi: 10.1097/MED.0b013e32833c5c48. Curr Opin Endocrinol Diabetes Obes. 2010. PMID: 20585247 Free PMC article. Review.

6

The outliers become a stampede as immunometabolism reaches a tipping point.

Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV. Nikolajczyk BS, et al. Immunol Rev. 2012 Sep;249(1):253-75. doi: 10.1111/j.1600-065X.2012.01142.x. Immunol Rev. 2012. PMID: 22889227 Free PMC article. Review.

7

"Obesity-Associated" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk.

Denis GV, Palmer JR. Denis GV, et al. Cancer Prev Res (Phila). 2017 May;10(5):267-269. doi: 10.1158/1940-6207.CAPR-17-0083. Epub 2017 Apr 13. Cancer Prev Res (Phila). 2017. PMID: 28408379 Free PMC article.

8

Clinical trials for BET inhibitors run ahead of the science.

Andrieu G, Belkina AC, Denis GV. Andrieu G, et al. Drug Discov Today Technol. 2016 Mar;19:45-50. doi: 10.1016/j.ddtec.2016.06.004. Epub 2016 Jul 21. Drug Discov Today Technol. 2016. PMID: 27769357 Free PMC article. Review.

9

BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Nicholas DA, Andrieu G, Strissel KJ, Nikolajczyk BS, Denis GV. Nicholas DA, et al. Cell Mol Life Sci. 2017 Jan;74(2):231-243. doi: 10.1007/s00018-016-2320-0. Epub 2016 Aug 4. Cell Mol Life Sci. 2017. PMID: 27491296 Free PMC article. Review.

10

Healthy obese persons: how can they be identified and do metabolic profiles stratify risk?

Denis GV, Hamilton JA. Denis GV, et al. Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):369-76. doi: 10.1097/01.med.0000433058.78485.b3. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 23974763 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year